सभी नौकरियों पर वापस
D

Head Portfolio Ideation and Therapy Strategy

Drreddyslaboratorieslimited

Hyderabad · in पूर्णकालिक 1h ago

नौकरी विवरण

Role Purpose Lead enterprise portfolio choices BD-led asset selection and , strategy by translating long-term ambition into executable priorities, identifying differentiated opportunities and ensuring disciplined delivery through launch and value realization. Role Profile Reports to: Head - Portfolio and Strategy, India Business Team size: 4–5 team members Stakeholder ecosystem: Biologics (Clinico-Regulatory), India Business Cluster Heads, CEO - India Business, Business Development and Finance A. Portfolio Team Leadership & Therapy-Area Ownership Lead and develop portfolio team members assigned to defined therapy areas, ensuring clear ownership of Disease Area strategy, opportunity identification, asset evaluation, prioritization and portfolio progression. TA Strategy & Portfolio Gap Definition Lead Disease Area refreshes and translate unmet needs, evolving standards of care and treatment changes into portfolio priorities. Define therapy-area aspirations, ideation gaps and indication-expansion opportunities. Asset Evaluation & Prioritization Assess clinical differentiation, patient opportunity, commercial fit, competition, patents, FTO and exclusivity. Prioritize assets and maintain a balanced roadmap of high-value opportunities. BD / In-Licensing Route Strategy Compare BD, in-house and third-party routes based on value, complexity, cost, timeline, supply control and exclusivity. Recommend preferred and contingency routes with clear rationale and switch triggers. BD Partnering & Opportunity Enablement Enable partner mapping, competitive assessment, diligence and investment rationale for active pursuits. Provide differentiated alternatives and maintain decision cases for priority opportunities. BD Asset Selection & Clinico-Regulatory Strategy Map opportunities to divisions and co-create clinico-regulatory strategy for innovative and BD assets. Lead cross-functional diligence through NBTS and track selection, signing and closure conditions. Competitive Intelligence & Strategic Watchlist Monitor regulatory, clinical, patent and competitor developments and maintain the asset watchlist. Convert intelligence into timely changes in priority, route, forecast, timing and risk mitigation. Portfolio & New-Product Program Governance Govern selected assets across development, registration, sourcing, supply and launch readiness. Track execution dependencies, risks, decisions and actions through closure. B. Strategy Team Leadership & Strategy Partnering Lead, develop and deploy a team of Strategy Business Partners to support business units and therapy areas in strategic planning, execution governance, performance reviews and delivery of priority initiatives. Strategy Planning & Long-Term Aspiration Lead annual and multi-year strategic planning, translating enterprise, cluster and therapy-area ambition into integrated value, volume and business priorities. Align top-down aspirations with bottom-up market, brand and functional inputs; define guardrails for resource allocation, sequencing and trade-offs. Growth Strategy & Strategic Initiatives Identify new growth spaces, therapy areas, channels, markets, partnerships and business models. Build business cases and Go / No-Go recommendations; pilot and scale approved concepts with clear success and exit criteria. Market Intelligence, Foresight & Scenario Planning Develop market forecasts, strategic scenarios and early-warning indicators; test plan resilience under alternative futures. Brand Performance, RCA & Countermeasures Identify underperforming or strategically critical brands using market, performance, execution and capability indicators. Lead cross-functional root-cause analysis and govern countermeasures across Commercial, Medical, Supply and enabling functions. Strategic Execution & Performance Management Convert strategic moves into projects and SDPs with clear scope, ownership, outcomes and cross-functional dependencies. Track milestones, risks, course correction and benefits realization, including central productivity and leadership priorities. Business Governance, PMO & Annual Planning Own leadership-review governance, brand and portfolio planning, budgeting alignment and execution readiness. Convert approved priorities into initiatives, milestones, KPIs and dependencies; program-manage delivery through benefit realization and closure. Cluster Priority & New-Product Governance Program-manage cluster priorities, including M&A opportunities and new launches, through an integrated cross-functional PMO. Own new-product governance across opportunity, forecast, investment, readiness, execution, post-launch recalibration and learning. Key Outcomes Integrated long-term strategy translated into executable priorities. Disciplined delivery of strategic initiatives and growth programs. Prioritized, risk-mitigated portfolio with clear BD routes and partner options. Selected assets governed through diligence, development and launch readiness. Market and competitive intelligence converted into timely strategic and portfolio actions. Educational Qualification Graduation in Business Administration, Pharmaceutical Sciences, Chemistry, Economics, or a related field is mandatory. Post Graduation in Business Administration or a related field is mandatory. Minimum Work Experience 10+ years of experience across: Portfolio Management Corporate Strategy Business Development / Licensing Commercial Excellence New Product Planning Pharma / Biologics / Specialty Business Leadership Resident Skills Customer Value Proposition Market Intelligence Opportunity Analysis Regulatory Affairs Lean Methodologies Behavioural Skills Critical Thinking – Applies structured reasoning to evaluate complex problems and make sound strategic recommendations. Collaboration & Influence – Builds strong relationships across teams, facilitates alignment, and drives consensus in cross-functional settings. Execution Discipline – Demonstrates ownership, attention to detail, and follow-through in driving initiatives from strategy to results. Critical Exposures 10+ years of experience in growth strategy, sales, portfolio management or management consulting in the pharmaceutical domain is desired. Experience in market analysis using industry databases (IQVIA, Comcon, DRG, GlobalData) is desired. Exposure to evaluating new markets, channels and defining go-to-market strategies is desired. Exposure to creating board-level presentations and multi-year strategy plans for business vertical/country is preferred. Exposure to pilot testing designs for new business models and strategic initiatives is preferred. " Benefits Offered At Dr. Reddy’s we actively help to catalyse your career growth and professional development through personalised learning programs. The benefits you will enjoy at Dr. Reddy’s are on par with the best industry standards. They include, among other things and other essential equipment, joining & relocation support, family support (Maternity & Paternity benefits), learning and development opportunities, medical coverage for yourself and your family, life coverage for yourself. " Our Work Culture Ask any employee at Dr. Reddy’s why they come to work every day and they’ll say, because Good Health Can’t Wait. This is our credo as well as the guiding principle behind all our actions. We see healthcare solutions not only as scientific formulations, but as a means to help patients lead healthier lives, and we’re always attuned to the new and the next to empower people to stay fit. And to do this, we foster a culture of empathy and dynamism. People are at the core of our journey over the last few decades. They have been supported by an enabling environment that buoys individual ability while fostering teamwork and shared success. We believe that when people with diverse skills are bound together by a common purpose and value system, they can make magic. For more details, please visit our career website at https://careers.drreddys.com/#!/" Dr. Reddy’s Laboratories Ltd. is a leading multinational pharmaceutical company based across global locations. Each of our 24,000 plus employees comes to work every day for one collective purpose: to accelerate access to affordable and innovative medicines because Good Health Can’t Wait. We started in 1984 with a modest investment, 20 employees and a bold vision. Today, we have research and development centres, manufacturing facilities or a commercial presence in 66 countries. For nearly four decades, we have stood for access, affordability and innovation based on the bedrock of deep science, progressive people practices and robust corporate governance. As the pharmaceutical industry evolves and undergoes disruption, we see an opportunity – to strengthen our core further (the next steps) and to build the future (the new bets). ‘The Next and the New’ is how we aim to continue to be the partner of choice – purpose-driven, future-ready and sustainable. Our aim is to reach over 1.5 Bn+ patients across the world by 2030 by growing our core businesses and building for the future with sustainability at the core of our purpose and strategy. Sustainability for us means operating in a manner that respects people, planet and purpose – helping us conserve precious resources, serve our patients, create value for stakeholders, give back to society, fulfil our potential and maintain our integrity and transparency Dr Reddy’s maintains a work environment, free from discrimination and is an equal opportunity employer. We are committed to employ & nurture all qualified diverse workforce without regard to race, colour religion, nationality, sex, age, disability status, genetics, sexual orientation, gender expression, citizenship or any other characteristic or classification protected by applicable law(s) of the country we operate in. We treasure every talent, and recognize merit and diversity in our organization. "

मिलती-जुलती सक्रिय नौकरियां